Sukmawati Dewi, Fujimura Satoshi, Jitsukawa Sachie, Ito-Hirano Rie, Ishii Takamasa, Sato Tadayuki, Hayashi Ayato, Itoh Seigo, Mizuno Hiroshi, Daida Hiroyuki, Tanaka Rica
Department of Plastic and Reconstructive Surgery, Juntendo University School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo 113-8421, Japan.
Department of Cardiovascular Medicine, Juntendo University School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo 113-8421, Japan.
Regen Ther. 2015 Feb 23;1:38-44. doi: 10.1016/j.reth.2014.11.001. eCollection 2015 Jun.
One of the causes for poor vasculogenesis of diabetes mellitus (DM) is known to rise from the dysfunction of bone marrow-derived endothelial progenitor cells (BM EPCs). However, the origin of its cause is less understood. We aimed to investigate the effect of oxidative stress in early stage of diabetic BM-EPC and whether its vasculogenic dysfunction is caused by oxidative stress.
Bone marrow c-Kit+Sca-1+Lin- (BM-KSL) cells were sorted from control and streptozotocin-induced diabetic C57BL6J mice by flow cytometry. BM-KSLs were then assessed for vasculogenic potential (colony forming assay; EPC-CFA), accumulation of intracellular ROS (CM-H2DCFDA), carbonylated protein (ELISA), anti-oxidative enzymes expression (RT-qPCR) and catalase activity (Amplex Red).
Compared to control, DM BM-KSL had significantly lower EPC-CFUs in both definitive EPC-CFU and total EPC-CFU (p < 0.05). Interestingly, the oxidative stress level of DM BM-KSL was comparable and was not significantly different to control followed by increased in anti-oxidative enzymes expression and catalase activity.
Primitive BM-EPCs showed vasculogenic dysfunction in early diabetes. However the oxidative stress is not denoted as the major initiating factor of its cause. Our results suggest that primitive BM-KSL cell has the ability to compensate oxidative stress levels in early diabetes by increasing the expression of anti-oxidative enzymes.
已知糖尿病(DM)血管生成不良的原因之一是骨髓源性内皮祖细胞(BM-EPCs)功能障碍。然而,其病因的起源尚不清楚。我们旨在研究氧化应激对糖尿病早期BM-EPC的影响,以及其血管生成功能障碍是否由氧化应激引起。
通过流式细胞术从对照和链脲佐菌素诱导的糖尿病C57BL6J小鼠中分离骨髓c-Kit+Sca-1+Lin-(BM-KSL)细胞。然后评估BM-KSLs的血管生成潜力(集落形成试验;EPC-CFA)、细胞内活性氧(CM-H2DCFDA)积累、羰基化蛋白(ELISA)、抗氧化酶表达(RT-qPCR)和过氧化氢酶活性(Amplex Red)。
与对照相比,糖尿病BM-KSL在确定性EPC-CFU和总EPC-CFU中的EPC-CFUs均显著降低(p<0.05)。有趣的是,糖尿病BM-KSL的氧化应激水平与对照相当,无显著差异,随后抗氧化酶表达和过氧化氢酶活性增加。
原始BM-EPCs在糖尿病早期表现出血管生成功能障碍。然而,氧化应激并非其主要起始因素。我们的结果表明,原始BM-KSL细胞能够通过增加抗氧化酶的表达来补偿糖尿病早期的氧化应激水平。